Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by parkinsonism and cerebellar, autonomic, urinary, and/or pyramidal dysfunction. Urinary and erectile dysfunction (ED) symptoms are prominent early features in men with MSA. Autonomic failure, considered until recently to be the cause of ED in these men, is commonly expressed through symptoms of orthostatic hypotension (OH). The aim of this retrospective study is to examine the chronological relationship between the development of urogenital symptoms and those of OH in patients diagnosed with MSA and discuss its significance in the aetiology of ED in these patients. A total of 71 male patients, referred to a Uro-Neurology department with a diagnosis of 'probable MSA', were reviewed in terms of 'autonomic' symptoms onlyFOH and lower urinary tract symptoms, accompanied by EDFpresent at the time of their referral. Laboratory investigations including anal sphincter EMG and/or autonomic function tests (AFTs) were performed in 75 and 90% of the patients, respectively. At presentation, urinary complaints were recorded in 96% of patients and ED in all patients that this was inquired about. The onset of ED had preceded the onset of bladder symptoms in 58% and the onset of OH symptoms in 91% of these men. Bladder symptoms also preceded symptoms of OH in 76% of patients. Sphincter EMG was abnormal in 91% and AFTs in 77% of the patients tested. Almost all patients with abnormal EMG had troublesome urinary symptoms. AFTs showed similar sensitivity relating to symptoms. At presentation, urogenital symptoms are common in patients with probable MSA and are often not accompanied by symptoms of OH. The earlier occurrence of ED in men with MSA suggests a lack of a causal relationship to hypotension. The notion that MSA possibly affects the dopaminergic mechanism of erectile function is discussed.
Introduction
Multiple system atrophy (MSA) is a progressive neurodegenerative disease of undetermined aetiology, which affects both sexes 1 with a prevalence ranging between 2.3 and 4.9 per 100 000 in various studies, [2] [3] [4] and an incidence of 0.6 per 100 000 per year. 5 It usually begins in middle age, 1 hence prevalence rates among patients aged over 55 y are significantly higher (16.8-28.7 per 100 000), 4, 6 and probably underestimated as patients in the general population are often misdiagnosed. 4 The median survival from the first symptom is 9.3 y. 1, 7 MSA causes parkinsonism and cerebellar autonomic, urinary and pyramidal dysfunction in different combinations. 1 Urogenital symptoms comprise both storage and voiding complaints, namely frequency, urgency, nocturia, incomplete bladder emptying, and incontinence as well as erectile and ejaculatory dysfunction in male patients. Symptoms of orthostatic hypotension (OH), such as dizziness after meals, on standing and after exertion, and syncope or visual disturbances, are a typical feature of autonomic failure in MSA patients. 8 Although the symptom of postural hypotension is generally the most prominent, laboratory studies of patients with this disease show that dysregulation of blood pressure control is also present in other postural conditions. 9, 10 The pathophysiological basis for incontinence in MSA is believed to be due to the diffuse involvement of several different neural systems, 11 including the basal ganglia, striatum in particular, the pons, cerebellum and intermediolateral cell columns and Onuf's nucleus in the sacral spinal cord. 12 Suprapontine disease is thought to cause detrusor overactivity, whereas atrophy of the tracts conveying the parasympathetic innervation to the detrusor may be the cause of incomplete bladder emptying. The anterior horn cells that lie in Onuf's nucleus innervate the striated muscles of the urinary and anal sphincters 13 and their damage leads to denervation resulting in sphincter weakness or stress incontinence. Thus, a combination of bladder disorders means that incontinence is a prominent early feature of MSA.
Onuf's nucleus is spared in idiopathic Parkinson's disease (IPD), and for this reason external sphincter electromyography (SpEMG) has been used in some laboratories to detect neurogenic changes of motor unit potentials following anterior horn cell loss in MSA and so distinguish the condition from IPD. Although reports from these laboratories have shown electromyographic changes of chronic reinnervation in the motor units of the striated muscle of the sphincter in 75-100% of MSA patients compared to only 0-17% of IPD patients, [14] [15] [16] [17] [18] other studies have disputed this finding, and the test is not universally accepted. 19 However, SpEMG has been found to be clinically useful in identifying abnormalities found in patients subsequently diagnosed as having MSA, differentiating them from patients with IPD and coincidental urogenital symptoms. 20 The mean duration of a motor unit, representing the strongest evidence of chronic reinnervation changes in the sphincter when prolonged, was found to be exceedingly prolonged (416 ms) in MSA patients. Using a cutoff upper limit of 10 ms for the mean duration of 10 different motor units captured, the test was positive in 82% of patients subsequently diagnosed as having MSA.
Erectile dysfunction (ED) commonly affects men in their fifth decade, 21 but urogenital symptoms are also prominent features in early MSA. Urinary dysfunction appears to be more common and is often an earlier manifestation than are the symptoms of OH in MSA, 22 but the chronological relationship between the onset of development of ED and orthostatic hypotensive symptoms has not previously been examined. This study presents a retrospective analysis of symptoms and results of relevant laboratory investigations in patients subsequently diagnosed as having MSA.
Methods
A total of 71 male patients with a diagnosis of 'probable MSA' were referred to a Uro-Neurology department over a 4-y period, either for further investigations or for advice on management of erectile failure or urinary symptoms. The mean age at referral time was 52.5178.73 (age range 36À71) y, with a mean age of onset of symptoms at 52 y. Patients were considered as having 'probable MSA' in the presence of symptoms of parkinsonism, with the features of bradykinesia, rigidity, postural instability, and tremor, often poorly responsive to levodopa, or cerebellar dysfunction with gait and limb ataxia and dysarthria or autonomic failure, mainly orthostatic (postural) hypotension, or lower urinary tract dysfunction with urinary incontinence accompanied by erectile dysfunction in men. Concomitant diseases, such as diabetes mellitus, cardiovascular disease or hypertension that could account for the patients' urogenital or autonomic failure symptoms at presentation, had been ruled out before referral time.
The diagnosis of MSA was confirmed by a review of the hospital case notes 1-2 y after the patient had been seen in the department, when the course of the condition had progressed and the diagnosis was clinically evident according to established criteria. 23 
Clinical symptoms
The patients had presented with a variety of symptoms, including parkinsonism, stiffness and gait disturbance, symptoms of autonomic dysfunction and urinary/sexual dysfunction symptoms. Hospital case notes on these patients were examined and only autonomic and urogenital symptoms present at the time of the patient's referral were considered for the purposes of the study. Symptoms that developed in the interval between the patient's first referral and final establishment of an MSA diagnosis were not reviewed. Notes were examined according to a proforma: patients were regarded as having abnormal bladder function if they had nocturia, urgency, frequency, hesitancy, poor stream, incomplete bladder emptying, incontinence or constant/intermittent catheterization had become necessary. Complaints of erectile and/or ejaculatory dysfunction were noted. Symptoms of OH included complaints of dizziness, syncope, or visual disturbances following postural changes, meals or exercise. Other symptoms, such as neck 'coat hanger pain' and nonspecific symptoms of tiredness, lethargy and weakness, now considered as part of the spectrum of orthostatic hypotension, 8 were excluded at the time of the study.
Laboratory investigations
For diagnostic purposes, SpEMG and/or standard autonomic function tests (AFTs) were carried out. In
all, 75% of the patients had SpEMG and 90% had AFTs. SpEMG was performed according to the method described in Beck et al 24 and Palace et al 20 using a concentric needle electrode inserted into the subcutaneous layer of the external anal sphincter about 2 cm from the external anal orifice. The mean duration of 10 motor units was calculated and values greater than 10.0 ms were considered abnormal.
Screening AFTs were carried out as previously described. 25 These evaluated cardiovascularFblood pressure and heart rateFresponses to postural change, with the head-up tilt at 451 and standing at 2 and 5 min, the Valsalva manoeuvre (raising and sustaining intrathoracic pressure to 40 mmHg for 10 s by blowing with an open glottis into a disposable syringe connected to the mercury column of a sphygmomanometer), pressor stimuli tests including isometric exercise (sustained handgrip of a dynamometer or a partially inflated sphygmomanometer for 3 min), cortical arousal by mental arithmetic (subtraction or addition of 7 or 17), deep breathing and hyperventilation (evaluating heart rate responses in conjunction with the head-up tilt, standing and the Valsalva manoeuvre). OH was defined as a fall of more than 20 mmHg systolic or 10 mmHg diastolic blood pressure on standing. Blood pressure recordings were performed using both a noninvasive system (Ohmeda 2300 Finapres BP Monitor, Englewood, CO 80112 5810, USA), which provides beat-to-beat pressure changes by measuring finger arterial blood pressure, and an automated sphygmomanometer measuring brachial blood pressure.
Results

Symptoms
In accordance with the specialized nature of the department to which the patients had been referred, urinary complaints were present in 96% of them; in those men (3/71) who did not present with urinary symptoms, ED was their presenting complaint ( Figure 1) . Parkinsonism, akinetic rigid syndrome and gait disturbance were, respectively, present in 53, 6 and 10% of the patients at referral time.
Inquiries about erectile function had been made in 63/71 male patients, all of whom complained of ED. The onset of ED had preceded the onset of bladder symptoms in 58% of the men questioned. In all, 95% of patients with ED also had urinary symptoms and 68% had symptomatic OH (Figure 1 ). In 91% of them, ED had preceded symptoms of hypotension and in 9% both sets of symptoms had come on at what was estimated to be 'the same time'.
Urinary symptoms were not accompanied by symptoms of OH in 37% (25/67, data missing from four patients) of patients. Lower urinary tract symptoms preceded those of OH in 76% of patients. All patients with OH also presented with urinary/ sexual dysfunction. Symptoms of OH preceded those of bladder dysfunction in only 16% of patients.
Laboratory findings
SpEMG was performed in 75% (53/71) of the patients and was abnormal at the time of referral in 91% (48/53) of those tested (Figure 1 ). Three out of 53 (5.6%) men had abnormal SpEMG but no urinary symptoms. There were five patients (9.4%) with urinary symptoms but normal SpEMG.
At presentation, screening AFTs were performed in 64/71 (90%) patients. Normal findings were recorded in 15/64 (23%) of the patients tested ( Figure 1) . In all, 10% of the patients had abnormal AFTs and no cardiovascular-related autonomic symptoms. Autonomic symptoms but normal AFTs were even less common, occurring in only 3% of the patients tested.
Discussion
Until recently, the prevailing view was that ED in MSA is part of the problem of 'autonomic failure'. 23 However, the results of this retrospective clinical study of the chronological development of symp- Urogenital dysfunction in MSA K Kirchhof et al toms shows that ED, although common in patients with probable MSA, is not often accompanied by symptoms of OH, which is the indication of autonomic failure. Although it was already known that ED is often the first symptom of MSA, in a study of genitourinary dysfunction in 62 patients with MSA, 96% of the men had ED, with this as the first symptom in 37%, 24 the chronological relationship with onset of hypotension was not documented. Sakakibara et al 22 found that 48% of patients with MSA who developed urinary and OH symptoms reported an earlier onset for urinary symptoms, but did not include data relating to ED. The abnormalities on laboratory tests relating to symptoms, that is, SpEMG and screening autonomic function tests to clinical histories, showed comparable sensitivity in this study and support the clinical observation that in the majority of patients in whom a secure diagnosis of MSA is made, urogenital abnormalities precede cardiovascular abnormalities. The findings of this study and the recent observation that men with MSA could demonstrate an erectile response to oral sildenafil despite an exacerbation of their hypotension, 26 suggests ED in men with MSA is not secondary to the dysregulation of blood pressure control.
There are a number of possible interpretations for these observations: Although the autonomic nervous system control of urogenital function and blood pressure are both affected by this progressive neurodegenerative disorder, symptoms of urogenital dysfunction may be expressed earlier. Compensatory mechanisms are thought to play an important role in reducing the symptoms and detectability of early abnormalities of cardiovascular autonomic dysfunction. That compensatory mechanisms are important in preventing symptomatic hypotension in MSA has already been indirectly shown 8 and is evidenced here by the higher incidence of abnormal AFTs compared with symptomatic cardiovascular abnormalities.
An alternative view is that there are separate neurological pathways that control urogenital and cardiovascular systems and that the neural substrate of urogenital control is selectively attacked, often at an early stage of the disease. The parasympathetic pathway, partially responsible for autonomic penile innervation, arises from neurons in the intermediolateral cell columns of the S2-S4 spinal cord segments, whereas Onuf's nucleus is considered the centre of somatomotor penile innervation, through the pudendal nerves, which innervate the ischiocavernosus and bulbocavernosus muscles. 27, 28 Contraction of the former is essential for the rigid phase of penile erection, while rhythmic contraction of the latter is necessary for ejaculation. Damage to either the intermediolateral cell column or Onuf's nucleus in MSA may, therefore, be responsible for sexualFerectile and/or ejaculatoryFdysfunction in MSA.
A further alternative theory is that the majority of patients with MSA develop parkinsonian motor disorders at some stage of the disease, as a manifestation of basal ganglia dopamine deficiency. Movement disorders, comprising parkinsonism, akinetic rigid syndrome and gait disturbance, were present in 53, 6 and 10% of our patients, respectively, at referral time. Results of this study proposing a dissociation of ED from autonomic failure in MSA together with accumulating experimental evidence that dopaminergic mechanisms are involved in penile erection, 29 may indicate that an impairment of dopaminergic-mediated pathways in the central nervous system is responsible for the early occurrence of ED in MSA. Both neuroanatomical and pharmacological experimental animal data provide evidence for the role of dopamine in erectile function; in rats, central dopaminergic neurons project both to the medial preoptic area (MPOA) and the paraventricular nucleus (PVN), whereas dopaminergic neurons have also been identified, travelling from the hypothalamus to innervate the lumbosacral spinal cord, suggesting a role for dopamine in the central regulation of both the autonomic and somatic components of penile reflexes.
29 D2 dopaminergic agonists induce erection in rats and monkeys, 30 whereas studies showing that sublingually delivered apomorphine, a D1 and D2 agonist, can successfully induce penile erections in men with erectile dysfunction constitute the strongest indication so far for the role of dopamine in the control of penile erection in humans. 30 Although the proerectile effect of dopamine in humans was initially suggested by observations of increased sexual activity in patients with Parkinson's disease treated with dopamine agonists, 31, 32 the explanation for ED in Parkinson's disease remains unclear. Erectile function in these men improves with apomorphine, 33 suggesting that a central dopamine deficiency is important. Whether, as in MSA where there is often motor refractoriness to L-dopa or dopaminergic agents, there may be a similar effect of such agents on ED remains to be seen.
In 42% of our patients, ED coincided chronologically or was a later feature than bladder dysfunction, and in 9% it appeared at the same time with symptoms of OH. A combination of urinary and erectile dysfunction might be an alerting sign for the examining physician towards a possible common underlying neurological pathology. Moreover, it is quite common for men with ED to postpone seeking medical advice and/or treatment, thus raising the possibility that other features of MSA such as orthostatic hypotension or parkinsonism will develop clinically by the time the patient requires a specialist's assistance.
It is important that those specialists to whom patients with MSA may initially present (urologists, andrologists and uro-gynecologists) recognize Bladder dysfunction may also occur in patients with IPD, resulting from coincidental urological problems such as benign prostatic hyperplasia, or in advanced disease from the neuropathological lesions of the disease per se or from anti-parkinsonian medication. Although frequency and urgency may occur in patients with long-standing IPD, the severity of urogenital dysfunction in MSA is greater and incontinence occurs at an early stage of the condition. Increased postvoid residual urine volume and ED are common features in early MSA but not in IPD. The urogenital criteria that favour a diagnosis of MSA in patients with parkinsonism have been described before and are of relevance to management. 34 For example, surgical intervention for incontinence in MSA has a poor outcome and should be avoided, whereas medical management with anticholinergics and intermittent catheterizations can effectively alleviate symptoms for many years. Also, men with MSA and OH who take sildenafil citrate for ED are at a significant risk of exacerbating OH. 26 
Conclusions
At presentation, urogenital symptoms are common in patients with probable MSA and are often not accompanied by symptoms of OH. The earlier occurrence of ED in men with MSA suggests lack of a causal relation to hypotension and may implicate dopaminergic pathways. The predominance of urogenital symptoms in early MSA could be of diagnostic and therapeutic value to specialists dealing with lower urinary tract and sexual dysfunction.
